| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/10/2013 | CN102372768B Soybean phosphorus transportprotein GmPHT15 and application thereof |
| 07/10/2013 | CN102329388B Production method for Pichia pastoris expression recombinant human interleukin 11 |
| 07/10/2013 | CN102286491B Rice root growth control gene OsZRL |
| 07/10/2013 | CN102241767B Extraction method of bovine serum albumin |
| 07/10/2013 | CN102199203B Soybean GmFTL4 protein and GmFTL6 protein, and application thereof |
| 07/10/2013 | CN102146124B Soybean GmFTL3 protein and soybean GmFTL5 protein as well as applications thereof |
| 07/10/2013 | CN102079779B Soybean GmFTL1 protein and soybean GmFTL2 protein as well as applications thereof |
| 07/10/2013 | CN102060920B Construction of abrin A chain mutant and application as candidate vaccine antigen |
| 07/10/2013 | CN101891806B Anti-flavivirus envelope E protein monoclonal antibody and application thereof |
| 07/10/2013 | CN101874109B Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same |
| 07/10/2013 | CN101292037B Autoactivated resistance protein |
| 07/10/2013 | CN101238216B Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 07/10/2013 | CN101151275B Methods for reducing the immunogenicity of cytokines and removal of cell surface markers |
| 07/09/2013 | US8481824 Inbred maize variety PH17P5 |
| 07/09/2013 | US8481823 Inbred maize variety PH17JT |
| 07/09/2013 | US8481822 Inbred maize variety PH18DS |
| 07/09/2013 | US8481821 Inbred maize variety PH17CP |
| 07/09/2013 | US8481819 Maize variety inbred PH12FT |
| 07/09/2013 | US8481816 Sweetpotato SRD1 cDNA and transgenic plants with high-numbered storage roots using the same |
| 07/09/2013 | US8481809 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 07/09/2013 | US8481692 Compositions relating to a mutant Clostridium difficile toxin and methods thereof |
| 07/09/2013 | US8481686 Antibodies that bind stresscopin peptides |
| 07/09/2013 | US8481682 Maize cellulose synthases and uses thereof |
| 07/09/2013 | US8481681 Silk proteins |
| 07/09/2013 | US8481680 Mutant smoothened and methods of using the same |
| 07/09/2013 | US8481678 Peptide-based tooth whitening reagents |
| 07/09/2013 | US8481676 Protein and production process and use thereof |
| 07/09/2013 | US8481504 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications |
| 07/09/2013 | US8481491 Scaffold polypeptides for heterologous peptide display |
| 07/09/2013 | US8481490 Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis |
| 07/09/2013 | US8481479 Formulations of factor VIIa inhibitors and utility |
| 07/09/2013 | US8481332 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit |
| 07/09/2013 | US8481262 Method for enriching and/or separating prokaryotic DNA using a protein that specifically bonds to unmethylated DNA containing CpG-motifs |
| 07/09/2013 | US8481255 Scytovirin domain 1 related polypeptides |
| 07/09/2013 | US8481057 Chlamydial antigens |
| 07/09/2013 | US8481051 Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof |
| 07/09/2013 | US8481049 Methods for treating a wound using epidermal growth factor formulation |
| 07/09/2013 | US8481048 Methods for preparing immunogenic conjugates |
| 07/09/2013 | US8481046 VEGF antagonist formulations for intravitreal administration |
| 07/09/2013 | US8481045 Immunogenic protein constructs |
| 07/09/2013 | US8481042 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents |
| 07/09/2013 | US8481040 Carrier for targeting nerve cells |
| 07/09/2013 | US8481031 Methods and compositions using Klotho-FGF fusion polypeptides |
| 07/09/2013 | US8481021 IL-1F5 polypeptides |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | CA2648936C Glp-1 compounds |
| 07/09/2013 | CA2588221C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 07/09/2013 | CA2575218C Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 07/09/2013 | CA2566925C Genotoxic testing |
| 07/09/2013 | CA2565678C Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 07/09/2013 | CA2558246C Hsv-2 type-specific immunoassays using glycoprotein g2 peptides |
| 07/09/2013 | CA2541840C P185neu-encoding dna and therapeutical uses thereof |
| 07/09/2013 | CA2524403C Active variants of the il-18 binding protein and medical uses thereof |
| 07/09/2013 | CA2506538C Bacterial superantigen vaccines |
| 07/09/2013 | CA2445593C Genetically modified yt cell line and use thereof |
| 07/09/2013 | CA2437583C Dna markers for meat tenderness |
| 07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
| 07/09/2013 | CA2349468C Factor viii polypeptide having factor viii:c activity |
| 07/04/2013 | WO2013102149A1 Truncated human vitamin d binding protein and mutation and fusion thereof and related materials and methods of use |
| 07/04/2013 | WO2013102047A1 Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers |
| 07/04/2013 | WO2013101645A1 Compositions and methods for regulating glucose metabolism |
| 07/04/2013 | WO2013101509A2 Hsp70 fusion protein conjugates and uses thereof |
| 07/04/2013 | WO2013100855A1 A novel phosphotyrosine-binding structure |
| 07/04/2013 | WO2013100721A1 Novel antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated four times, and use thereof |
| 07/04/2013 | WO2013098852A2 Allium fistulosum leaf agglutinin rcombinant protein, its encoding polynucleotide, primer and process for preparation thereof |
| 07/04/2013 | WO2013098819A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing yield of plants |
| 07/04/2013 | WO2013098755A2 Anticancer fusion protein |
| 07/04/2013 | WO2013098676A1 Method for purifying factor viii |
| 07/04/2013 | WO2013098339A1 Anti-tumor adjuvant therapy |
| 07/04/2013 | WO2013098337A1 Cell-penetrating peptides |
| 07/04/2013 | WO2013098244A1 Modified cascade ribonucleoproteins and uses thereof |
| 07/04/2013 | WO2013098191A1 Dipeptide comprising a non-proteogenic amino acid |
| 07/04/2013 | WO2013097940A1 Plants having a modulated content in seed proteins and method for production thereof |
| 07/04/2013 | WO2013075066A3 Variant serum albumin with improved half -life and other properties |
| 07/04/2013 | WO2013052799A3 Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| 07/04/2013 | WO2012117116A3 Enhanced tumor therapy by tumor stem cell targeted oncolytic viruses |
| 07/04/2013 | WO2011159826A3 Hcv ns5b polymerase mutants |
| 07/04/2013 | US20130174289 Na+/Mg2+ Exchanger |
| 07/04/2013 | US20130172985 Crosslinked hydrogels and methods of making and using thereof |
| 07/04/2013 | US20130172535 Process for protein extraction |
| 07/04/2013 | US20130172532 Method for making rhenium-186/188 labeled human serum albumin microspheres and kit for making the same and method for using the kit |
| 07/04/2013 | US20130172531 Human placental collagen compositions, and methods of making and using the same |
| 07/04/2013 | US20130172530 Novel JNK Inhibitor Molecules |
| 07/04/2013 | US20130172262 Compound and method for treatment of alzheimer's disease and familial dementia |
| 07/04/2013 | US20130172259 Modified vitamin k-dependent polypeptides |
| 07/04/2013 | US20130172258 Angiogenesis-inhibiting peptide and application thereof |
| 07/04/2013 | US20130172257 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 07/04/2013 | US20130172254 Buffers for Controlling the pH of Bone Morphogenetic Proteins |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/04/2013 | US20130172247 Insulin Analogues Containing Additional Disulfide Bonds |
| 07/04/2013 | US20130172242 Growth hormone secretatogue receptor antagonists and uses thereof |
| 07/04/2013 | US20130172229 Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences |
| 07/04/2013 | US20130171730 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 07/04/2013 | US20130171727 T1r taste receptors and genes encoding same |
| 07/04/2013 | US20130171719 Recombinant aav production in mammalian cells |
| 07/04/2013 | US20130171716 Animal product free system and process for purifying a botulinum toxin |
| 07/04/2013 | US20130171677 Recombinant phycobiliproteins with enhanced fluorescence and photochemical properties |
| 07/04/2013 | US20130171669 Porous membranes having a hydrophilic coating and methods for their preparation and use |
| 07/04/2013 | US20130171668 Disulphide bond-stabilized functional soluble mhc class ii heterodimers |